Articles by Daniel Marsh
Dow Futures Edge Higher Ahead of PPI; Nasdaq Dips as Oil Tops $102
Dow futures edged up before August PPI, but Nasdaq-100 futures fell as Brent crude topped $102. Investors await inflation data to gauge rate and growth outlook.
AT&T's Amazon Leo Pact: Strategic Win, Financial Impact Still Unclear
AT&T's deal to distribute Amazon's Leo satellite broadband is a strategic distribution win, but without financial details, it's not yet an earnings catalyst.
Enbridge's Tallgrass Deal: Dilution vs. Growth
Enbridge's $2.55B Tallgrass acquisition brings contracted pipeline cash flows but 1.8% dilution. Investors weigh growth vs. per-share impact.
Spotify and Live Nation Test Playlist-to-Live-Event Model in Dallas
Spotify and Live Nation Urban partner on RNB X Live, a one-day R&B concert in Dallas, testing whether a playlist can become a repeatable live-event franchise.
Xero Shares Tumble 15% in Five Sessions: Is A$68.79 the Bottom?
Xero's stock dropped 15% in five sessions to A$68.79. Despite strong growth, Melio acquisition costs and execution risks keep valuation debate alive.
PG&E's 8.6x Earnings: A Bargain or a Trap?
PG&E's stock dropped 4.25% to $14.19, trading at 8.6x earnings. But the discount reflects ongoing wildfire financing risks. Is this a value play or a trap?
Live Nation's Mental-Health Fund: Strategic, Not a Stock Mover
Live Nation's backing of a £272,000 mental-health fund for touring crews is a strategic move, but it won't affect LYV stock. The amount is minuscule relative to its revenue.
Canadian Fixed Mortgage Rates Climb Despite BoC Hold; Bank Investors Eye Renewals
Fixed mortgage rates in Canada are rising due to higher bond yields, despite the Bank of Canada holding its policy rate at 2.25%. Banks face a mixed outlook as higher yields boost margins but volumes and credit risks loom.
Synergy CHC Surges 68% Pre-Bankruptcy: Will Shareholders See Any Recovery?
Synergy CHC shares soar 68% premarket after Chapter 11, but the bankruptcy math leaves little room for common stock recovery.
Tenon Medical Stock Swings Wildly After Debt Payoff—What's Next?
TNON rebounded 42% premarket after a 27% plunge, but new warrants and cash burn keep dilution risk alive. Key disclosures ahead.
AC/DC Toronto Cancel: Live Nation's Real Risk Is Stadium Rebuild
Live Nation's AC/DC Toronto cancellation triggers refunds and stadium rebuild costs, but the bigger investor concern is who bears the expense and what it means for venue portfolio returns.
Analog Devices' Alif Buy: Strategic Fit, But Returns Unproven
Analog Devices' $1.55B Alif acquisition is affordable but lacks key financials, leaving returns unproven.